Who owns IPSC?
Institutional ownership of Century Therapeutics Inc. from Form 13F, Q2 2026
99 institutional managers reported holding Century Therapeutics Inc. (IPSC) in Form 13F filings for Q2 2026, with 158,001,283 shares worth $387M. The largest reported holder was Ra Capital Management, L.p. Managers that filed both quarters added a net 20,649,709 shares (+15.0%). 38 opened new positions and 10 sold out.
- Funds holding
- 99
- Value held
- $387M
- New / sold out
- 38 / 10
- Net shares, same filers
- +15.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of IPSC
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Ra Capital Management, L.p. | $43.5M | 11.2% | 17,754,430 | Unchanged |
| TCG Crossover Management, LLC | $43.4M | 11.2% | 17,754,430 | Unchanged |
| Versant Venture Management, LLC | $29.8M | 7.7% | 12,166,109 | Unchanged |
| Deep Track Capital, LP | $23.2M | 6.0% | 9,462,645 | Trimmed |
| RTW Investments, LP | $21.3M | 5.5% | 8,695,652 | Unchanged |
| Commodore Capital LP | $21.3M | 5.5% | 8,695,652 | Unchanged |
| Venrock Adviser, LLC | $21.3M | 5.5% | 8,695,652 | Unchanged |
| BlackRock, Inc. | $19.8M | 5.1% | 8,091,768 | Added |
| Vanguard Capital Management LLC | $14.0M | 3.6% | 5,703,680 | Added |
| Balyasny Asset Management L.P. | $13.5M | 3.5% | 5,522,944 | Added |
| Point72 Asset Management, L.P. | $12.2M | 3.2% | 4,980,526 | Trimmed |
| Seven Fleet Capital Management LP | $10.7M | 2.8% | 4,347,826 | Added |
| Woodline Partners LP | $10.4M | 2.7% | 4,257,530 | Added |
| Millennium Management LLC | $10.3M | 2.7% | 4,194,981 | Trimmed |
| Trails Edge Capital Partners, LP | $10.1M | 2.6% | 4,134,969 | Added |
| Spruce Street Capital LP | $9.9M | 2.6% | 4,059,054 | Unchanged |
| Adage Capital Partners GP, L.l.c. | $9.3M | 2.4% | 3,789,538 | Unchanged |
| Geode Capital Management, LLC | $7.3M | 1.9% | 2,979,529 | Added |
| Two Sigma Investments, LP | $6.6M | 1.7% | 2,699,013 | Added |
| DAFNA Capital Management LLC | $5.9M | 1.5% | 2,400,458 | Trimmed |
| Stempoint Capital LP | $5.3M | 1.4% | 2,146,182 | New |
| State Street Corp | $4.5M | 1.2% | 1,843,154 | Added |
| Northern Trust Corp | $3.9M | 1.0% | 1,593,944 | Added |
| DV Trading LLC | $3.4M | 0.9% | 1,400,000 | New |
| Rock Springs Capital Management LP | $3.2M | 0.8% | 1,304,347 | Unchanged |
Share of 13F holdings is each fund's shares as a share of the 158,001,283 IPSC shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$16.1M
- Stempoint Capital LP New+$5.3M
- Trails Edge Capital Partners, LP Added+$4.1M
- Geode Capital Management, LLC Added+$4.1M
- State Street Corp Added+$3.6M
- Seven Fleet Capital Management LP Added+$3.4M
- DV Trading LLC New+$3.4M
- Northern Trust Corp Added+$3.3M
- Woodline Partners LP Added+$3.0M
- Vanguard Portfolio Management LLC New+$2.5M
Biggest sellers in Q2 2026
- Syncona Portfolio Ltd Sold out-$2.7M
- Point72 Asset Management, L.P. Trimmed-$2.4M
- Millennium Management LLC Trimmed-$1.2M
- Acadian Asset Management LLC Sold out-$627K
- Marshall Wace, LLP Trimmed-$332K
- Susquehanna International Group, LLP Trimmed-$272K
- Superstring Capital Management LP Sold out-$270K
- Barclays PLC Trimmed-$234K
- Brevan Howard Capital Management LP Sold out-$218K
- Goldman Sachs Group Inc Trimmed-$147K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $59.9M and sold $9.0M; 27 added and 12 trimmed.
Schedule 13D and 13G filings on IPSC
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-15RTW INVESTMENTS, LP SCHEDULE 13G filed by Century Therapeutics Inc.Schedule 13G
- 2026-01-16RA CAPITAL MANAGEMENT, L.P. SCHEDULE 13G filed by Century Therapeutics Inc.Schedule 13G
- 2026-01-16Venrock Healthcare Capital Partners III, L.P. SCHEDULE 13G filed by Century Therapeutics Inc.Schedule 13G
- 2026-01-16Commodore Capital LP SCHEDULE 13G filed by Century Therapeutics Inc.Schedule 13G
- 2026-01-05Point72 Asset Management, L.P. SCHEDULE 13G filed by Century Therapeutics Inc.Schedule 13G
Questions about IPSC ownership
- Who owns IPSC stock?
- 99 institutional investment managers reported IPSC positions in their Form 13F filings for Q2 2026, holding 158,001,283 shares worth $387M in total. Ra Capital Management, L.p. reported the largest position.
- Are funds buying or selling IPSC?
- In Q2 2026, 38 managers opened new IPSC positions, 27 added, 12 trimmed and 10 sold out. Managers that filed in both quarters added a net 20,649,709 shares.
- How current is this IPSC institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IPSC by CUSIP. Options are left out. IPSC news and filings · IPSC insider trades · Top funds